In COVID-19, T2DM or hyperglycaemia affected the numbers of immune cells, including CD4+, CD8+ T cells, and NK cells, and reduced Th1/Th2 cytokine ratios, which might aggravate the severity of COVID-19. This evidence concerns the gene CD8A and COVID-19.